| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.662 | 9.528 | 3.721 | 48.504 | 62.600 | 4.306 | 469.928 | 1.255.454 | 367.548 | 757.063 |
| Total Income - EUR | 48.662 | 9.528 | 3.721 | 48.542 | 62.605 | 4.709 | 470.035 | 1.275.482 | 420.491 | 790.400 |
| Total Expenses - EUR | 1.046 | 107 | 562 | 15.400 | 27.791 | 6.666 | 217.982 | 1.135.509 | 304.413 | 483.475 |
| Gross Profit/Loss - EUR | 47.616 | 9.421 | 3.160 | 33.142 | 34.814 | -1.956 | 252.053 | 139.973 | 116.078 | 306.925 |
| Net Profit/Loss - EUR | 46.156 | 9.135 | 3.048 | 31.685 | 32.936 | -2.087 | 248.289 | 120.259 | 99.524 | 262.297 |
| Employees | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Winpharmamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 1.034 | 32.759 | 9.208 | 9.277 | 48.340 |
| Current Assets | 53.979 | 9.203 | 12.675 | 37.796 | 53.811 | 30.780 | 276.354 | 452.362 | 506.659 | 780.209 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 6.817 | 92.873 | 83.110 | 127.468 |
| Receivables | 53.790 | 1.977 | 1.532 | 31.238 | 0 | 591 | 0 | 1.743 | 8.634 | 36.815 |
| Cash | 189 | 7.226 | 11.142 | 6.558 | 53.811 | 30.189 | 269.537 | 357.747 | 414.914 | 615.926 |
| Shareholders Funds | 53.574 | 9.188 | 12.081 | 31.737 | 32.987 | 30.275 | 277.892 | 399.013 | 497.327 | 262.346 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 405 | 15 | 594 | 6.059 | 20.825 | 1.539 | 31.256 | 69.057 | 18.609 | 566.204 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Winpharmamed Srl